{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:11:17Z","timestamp":1778901077622,"version":"3.51.4"},"reference-count":17,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Diseases"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.vasdi.2026.03.001","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:13:45Z","timestamp":1777608825000},"page":"113-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Is lymphedema an inflammatory disease?"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6745-1469","authenticated-orcid":false,"given":"St\u00e9phane","family":"Vignes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vasdi.2026.03.001_bib0090","article-title":"Cellulitis risk factors for patients with primary or secondary lymphedema","volume":"10","author":"Vignes","year":"2022","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"10.1016\/j.vasdi.2026.03.001_bib0095","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/PRS.0b013e3182450b2d","article-title":"Regulation of adipogenesis by lymphatic fluid stasis: part I. Adipogenesis, fibrosis, and inflammation","volume":"129","author":"Zampell","year":"2012","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.vasdi.2026.03.001_bib0100","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/RLI.0000000000000386","article-title":"Magnetic resonance imaging-based assessment of breast cancer-related lymphoedema tissue composition","volume":"52","author":"Borri","year":"2017","journal-title":"Invest Radiol"},{"key":"10.1016\/j.vasdi.2026.03.001_bib0105","doi-asserted-by":"crossref","first-page":"R14","DOI":"10.1186\/gb-2008-9-1-r14","article-title":"Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity","volume":"9","author":"Henegar","year":"2008","journal-title":"Genome Biol"},{"key":"10.1016\/j.vasdi.2026.03.001_bib0110","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.3390\/ijms25073907","article-title":"The role of inflammation in lymphedema: a narrative review of pathogenesis and opportunities for therapeutic intervention","volume":"25","author":"Bowman","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.vasdi.2026.03.001_bib0115","doi-asserted-by":"crossref","first-page":"H1065","DOI":"10.1152\/ajpheart.00598.2014","article-title":"Regulation of inflammation and fibrosis by macrophages in lymphedema","volume":"308","author":"Ghanta","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.vasdi.2026.03.001_bib0120","doi-asserted-by":"crossref","first-page":"H1426","DOI":"10.1152\/ajpheart.01019.2013","article-title":"IL-6 regulates adipose deposition and homeostasis in lymphedema","volume":"306","author":"Cuzzone","year":"2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.vasdi.2026.03.001_bib0125","doi-asserted-by":"crossref","first-page":"330e","DOI":"10.1097\/PRS.0000000000009866","article-title":"The vicious circle of stasis, inflammation, and fibrosis in lymphedema","volume":"151","author":"Brown","year":"2023","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.vasdi.2026.03.001_bib0130","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1089\/lrb.2013.0024","article-title":"Cytokine candidate genes predict the development of secondary lymphedema following breast cancer surgery","volume":"12","author":"Leung","year":"2014","journal-title":"Lymphat Res Biol"},{"key":"10.1016\/j.vasdi.2026.03.001_bib0135","doi-asserted-by":"crossref","first-page":"e123775","DOI":"10.1172\/jci.insight.123775","article-title":"Pilot studies demonstrate the potential benefits of antiinflammatory therapy in human lymphedema","volume":"3","author":"Rockson","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.vasdi.2026.03.001_bib0140","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1161\/CIRCRESAHA.121.318307","article-title":"Advances in lymphedema","volume":"128","author":"Rockson","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.vasdi.2026.03.001_bib0145","article-title":"Trial of acebilustat for the treatment of upper arm lymphedema (HEAL)","author":"Rockson","year":"2022","journal-title":"ClinicalTrials.Gov"},{"key":"10.1016\/j.vasdi.2026.03.001_bib0150","doi-asserted-by":"crossref","first-page":"e758","DOI":"10.1002\/ctm2.758","article-title":"TGF-\u03b21 mediates pathologic changes of secondary lymphedema by promoting fibrosis and inflammation","volume":"12","author":"Baik","year":"2022","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.vasdi.2026.03.001_bib0155","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1089\/lrb.2018.0070","article-title":"EW-7197, a transforming growth factor-beta type I receptor kinase inhibitor, ameliorates acquired lymphedema in a mouse tail model","volume":"18","author":"Yoon","year":"2020","journal-title":"Lymphat Res Biol"},{"key":"10.1016\/j.vasdi.2026.03.001_bib0160","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4048\/jbc.2023.26.e2","article-title":"Treatment of breast cancer-related lymphedema with topical tacrolimus: a prospective, open-label, single-arm, phase II pilot trial","volume":"26","author":"Gulmark Hansen","year":"2023","journal-title":"J Breast Cancer"},{"key":"10.1016\/j.vasdi.2026.03.001_bib0165","doi-asserted-by":"crossref","first-page":"14345","DOI":"10.1038\/ncomms14345","article-title":"Topical tacrolimus for the treatment of secondary lymphedema","volume":"8","author":"Gardenier","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.vasdi.2026.03.001_bib0170","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13063-025-08829-3","article-title":"Topical tacrolimus for the amelioration of breast cancer-related lymphedema (TACLE trial): a study protocol for a randomized, double-blind, placebo-controlled phase II\/III trial","volume":"26","author":"Hansen","year":"2025","journal-title":"Trials"}],"container-title":["Vascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050658126001822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050658126001822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T02:25:31Z","timestamp":1778898331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3050658126001822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S3050658126001822"],"URL":"https:\/\/doi.org\/10.1016\/j.vasdi.2026.03.001","relation":{},"ISSN":["3050-6581"],"issn-type":[{"value":"3050-6581","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is lymphedema an inflammatory disease?","name":"articletitle","label":"Article Title"},{"value":"Vascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vasdi.2026.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}